X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15675) 15675
Book Chapter (100) 100
Dissertation (12) 12
Book / eBook (6) 6
Conference Proceeding (5) 5
Government Document (4) 4
Publication (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9070) 9070
animals (8800) 8800
mice (6532) 6532
cancer (5836) 5836
oncology (5804) 5804
antitumor immunity (5240) 5240
immunotherapy (5085) 5085
immunology (4010) 4010
female (4002) 4002
cell line, tumor (3442) 3442
tumors (3423) 3423
dendritic cells (3126) 3126
xenograft model antitumor assays (2566) 2566
apoptosis (2564) 2564
medicine, research & experimental (2331) 2331
male (2221) 2221
lymphocytes (2195) 2195
expression (2167) 2167
antitumor activity (2161) 2161
antitumor-activity (2108) 2108
in-vivo (1946) 1946
mice, inbred c57bl (1895) 1895
care and treatment (1857) 1857
t cells (1795) 1795
research (1791) 1791
mice, inbred balb c (1751) 1751
lymphocytes t (1716) 1716
health aspects (1670) 1670
neoplasms - immunology (1656) 1656
antigens (1629) 1629
melanoma (1621) 1621
cytotoxicity (1579) 1579
t-cells (1575) 1575
cell biology (1540) 1540
chemotherapy (1530) 1530
neoplasms - therapy (1472) 1472
biochemistry & molecular biology (1445) 1445
proteins (1435) 1435
cytokines (1423) 1423
metastasis (1420) 1420
immunity (1346) 1346
activation (1344) 1344
cancer therapies (1340) 1340
dendritic cells - immunology (1335) 1335
biotechnology & applied microbiology (1329) 1329
immune system (1312) 1312
analysis (1302) 1302
immune response (1295) 1295
therapy (1244) 1244
antineoplastic agents - pharmacology (1207) 1207
t-lymphocytes - immunology (1192) 1192
mice, nude (1189) 1189
gene expression (1162) 1162
cells (1142) 1142
immunotherapy - methods (1100) 1100
in-vitro (1090) 1090
flow cytometry (1076) 1076
cancer vaccines - immunology (1069) 1069
cell proliferation (1066) 1066
anticancer properties (1055) 1055
tumor cells, cultured (1046) 1046
vaccination (1044) 1044
genetics & heredity (1033) 1033
pharmacology & pharmacy (1021) 1021
disease models, animal (1020) 1020
cd8-positive t-lymphocytes - immunology (980) 980
metastases (978) 978
review (959) 959
inflammation (954) 954
vaccines (954) 954
multidisciplinary sciences (950) 950
t-lymphocytes, cytotoxic - immunology (929) 929
regulatory t-cells (921) 921
antigen (918) 918
medicine (913) 913
breast cancer (912) 912
signal transduction (912) 912
cell proliferation - drug effects (886) 886
research article (852) 852
clinical trials (848) 848
apoptosis - drug effects (847) 847
genetic aspects (843) 843
antitumor (839) 839
gene therapy (826) 826
middle aged (820) 820
antigens, neoplasm - immunology (815) 815
colony-stimulating factor (810) 810
hematology (804) 804
tumor microenvironment (796) 796
kinases (778) 778
cancer vaccines (774) 774
medical research (774) 774
inhibition (753) 753
induction (749) 749
metastatic melanoma (744) 744
antineoplastic agents - therapeutic use (735) 735
growth (721) 721
tumor cells (719) 719
responses (708) 708
neoplasms - pathology (704) 704
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15681) 15681
Japanese (69) 69
French (35) 35
Russian (25) 25
German (18) 18
Chinese (13) 13
Polish (12) 12
Spanish (8) 8
Korean (4) 4
Czech (2) 2
Portuguese (2) 2
Hungarian (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Journal of immunology (1950), ISSN 1550-6606, 2018, Volume 200, Issue 11, pp. 3729 - 3738
Journal Article
Nature (London), ISSN 1476-4687, 2015, Volume 527, Issue 7577, pp. 249 - 253
Epigenetic silencing including histone modifications and DNA methylation is an important tumorigenic mechanism. However, its role in cancer immunopathology and... 
Polycomb Repressive Complex 2 - antagonists & inhibitors | CD8-Positive T-Lymphocytes - cytology | Immunotherapy - methods | Prognosis | Histones - chemistry | Chemokine CXCL9 - biosynthesis | Humans | Ovarian Neoplasms - pathology | DNA (Cytosine-5-)-Methyltransferases - antagonists & inhibitors | Th1 Cells - immunology | DNA (Cytosine-5-)-Methyltransferases - metabolism | Th1 Cells - metabolism | Chemokine CXCL10 - biosynthesis | Chemokine CXCL10 - immunology | Female | Epigenesis, Genetic - drug effects | Lysine - metabolism | Tumor Cells, Cultured | Chemokines - immunology | Tumor Escape - immunology | Chemokines - biosynthesis | DNA (Cytosine-5-)-Methyltransferase 1 | Gene Silencing | Chemokine CXCL9 - immunology | Chemokine CXCL9 - genetics | Chemokines - genetics | Enhancer of Zeste Homolog 2 Protein | Ovarian Neoplasms - enzymology | Xenograft Model Antitumor Assays | B7-H1 Antigen - metabolism | Animals | Chemokine CXCL10 - genetics | Ovarian Neoplasms - therapy | Mice | Histones - metabolism | CD8-Positive T-Lymphocytes - immunology | Polycomb Repressive Complex 2 - metabolism | DNA Methylation - drug effects | Lymphocytes, Tumor-Infiltrating - immunology | Ovarian Neoplasms - immunology | checkpoint | CXCL9 | histone modification | chemotherapy | epigenetics | Chemokine | CXCL10 | DNMT | T cell therapy | DNA methylation | PD-L1 | B7-H1 | cancer | trafficking | PD-1 | EZH2
Journal Article
Journal Article
Frontiers in immunology, ISSN 1664-3224, 2019, Volume 10, p. 774
Reactivation of cytotoxic CD8(+) T-cell responses has set a new direction for cancer immunotherapy. Neutralizing antibodies targeting immune checkpoint... 
C3a | C1q | Cancer immunity | Immunotherapy | PD-L1 | Complement system | PD-1 | C5a | complement system | ACTIVATION PRODUCT C4D | FACTOR-H | cancer immunity | IMMUNOLOGY | ANAPHYLATOXIN C5A | C5A RECEPTOR | T-CELL RESPONSES | POOR-PROGNOSIS | immunotherapy | APOPTOTIC CELLS | THERAPEUTIC CONTROL | ANTITUMOR IMMUNITY | INTRACELLULAR COMPLEMENT
Journal Article